Researchers developed online calculators to assess patients’ likelihood of benefiting from liver resection for intrahepatic cholangiocarcinoma. Among 889 patients studied, the 90-day mortality rate was 8.5%, with median overall survival at 24.1 months. Risk profiles categorized patients into three groups: favorable (90-day mortality 4.3%, survival 47 months), unfavorable (33.3% mortality, 11.9 months survival), and intermediate (15.1% mortality, 29.9 months survival). The models promote tailored decision-making in clinical settings.
Journal Article by Altaf A, Khalil M (…) Pawlik TM et 19 al. in BMC Surg
Copyright © 2025 Elsevier Inc. All rights reserved.